To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Admission Hyperglycemia a… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

Admission Hyperglycemia and Clinical Outcome in Cerebral Venous Thrombosis

Journal article
Authors S. M. Zuurbier
S. Hiltunen
Turgut Tatlisumak
G. M. Peters
S. M. Silvis
E. Haapaniemi
N. D. Kruyt
J. Putaala
J. M. Coutinho
Published in Stroke
Volume 47
Issue 2
Pages 390-+
ISSN 0039-2499
Publication year 2016
Published at Institute of Neuroscience and Physiology
Pages 390-+
Language en
Keywords coma, diabetes mellitus, hyperglycemia, risk factors, sinus thrombosis, intracranial, stroke, intensive insulin therapy, critically-ill patients, dural sinus, thrombosis, intracerebral hemorrhage, stress hyperglycemia, stroke, trial, prognosis, glucose, vein, Neurosciences & Neurology, Cardiovascular System & Cardiology
Subject categories Cardiovascular medicine, Neurosciences


Background and Purpose-Admission hyperglycemia is associated with poor clinical outcome in ischemic and hemorrhagic stroke. Admission hyperglycemia has not been investigated in patients with cerebral venous thrombosis. Methods-Consecutive adult patients with cerebral venous thrombosis were included at the Academic Medical Center, The Netherlands (2000-2014) and the Helsinki University Central Hospital, Finland (1998-2014). We excluded patients with known diabetes mellitus and patients without known admission blood glucose. We defined admission hyperglycemia as blood glucose >= 7.8 mmol/L (141 mg/dL) and severe hyperglycemia as blood glucose >= 11.1 mmol/L (200 mg/dL). We used logistic regression analysis to determine if admission hyperglycemia was associated with modified Rankin Scale (mRS) score of 3 to 6 or mortality at last follow-up. We adjusted for: age, sex, coma, malignancy, infection, intracerebral hemorrhage, deep cerebral venous thrombosis, and location of recruitment. Results-Of 380 patients with cerebral venous thrombosis, 308 were eligible. Of these, 66 (21.4%) had admission hyperglycemia with 8 (2.6%) having severe admission hyperglycemia. Coma (31.3% versus 5.0%, P<0.001) and intracerebral hemorrhage (53.0% versus 32.6%, P=0.002) at presentation were more common among patients with admission hyperglycemia than normoglycemic patients. Patients with admission hyperglycemia had a higher risk of mRS score of 3 to 6 (adjusted odds ratio, 3.10; 95% confidence interval, 1.35-7.12) and mortality (adjusted odds ratio, 4.13; 95% confidence interval, 1.41-12.09). Severe hyperglycemia was even more strongly associated with mRS score of 3 to 6 (adjusted odds ratio, 11.59; 95% confidence interval, 1.74-77.30) and mortality (adjusted odds ratio, 33.36; 95% confidence interval, 3.87-287.28) compared with normoglycemic patients. Conclusions-Admission hyperglycemia is a strong predictor of poor clinical outcome in patients with cerebral venous thrombosis.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?